Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/10371
Title: Expansion Grade and Morphokinetic Parameters Associated with Aneuploidy Status of Embryo Fifth Day
Authors: Harzif, Achmad K.
Natadisastra, Muharam
Suryandari, Dwi A.
Werdhani, Retno A.
Jatmiko, Wisnu
Boediono, Arief
Bayuaji, Hartanto
Wiweko, Budi
Keywords: blastocyst
embryo
euploid status,
expansion grade
morphokinetics
Issue Date: Oct-2023
Publisher: Indones J Obstet Gynecol
Citation: Research Article
Abstract: Abstract Objective: To determine the potential of examining embryo morphology, and morphokinetic parameters in predicting the chromosomal status of embryos. Methods: This study is a cross-sectional that requires patients undergoing IVF followed by chromosome examination with NGS that was conducted at the IVF Center at Pondok Indah Hospital and Morula IVF Center at Bunda Hospital from December 2021 to December 2022. Each embryo that reaches the blastocyst stage on day 5 or 6 will be washed and put into a PCR tube for a week; then, embryologists annotate them to determine morphological assessment and morphokinetic parameters using Time-Lapse Microscopy. The chi-square test was used to analyse bivariate variables. Results: One hundred twenty-four samples were collected on day 5 of patients undergoing the IVF procedure. 50.8% of the samples were aneuploid chromosomes, and 49.2% were euploid. The morphokinetic characteristics median was 3.86 fold. It was found that expansion grade, time to pro-nuclear fading, and time to the synchrony of the third cell cycle were significantly associated with euploid status (p = 0.000; 0.041 and 0.036). Conclusion: The expansion grade has been proven as the most influential component for accurately predicting the ploidy status of embryos.
URI: http://localhost:8080/xmlui/handle/123456789/10371
Appears in Collections:Volume 11 No 4 2023

Files in This Item:
File Description SizeFormat 
5.pdf106.44 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.